v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities:    
Net loss $ (4,324,000) $ (5,165,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 100,000 160,000
Change in fair value of contingent consideration 21,000 202,000
Non-cash lease expense 120,000 108,000
Depreciation 26,000 39,000
Deferred research and development tax credit (409,000) (223,000)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 588,000 766,000
Accounts payable (440,000) (190,000)
Accrued expenses 295,000 382,000
Accrued employee benefits (603,000) (845,000)
Operating lease liability (130,000) (115,000)
Net Cash Used In Operating Activities (4,756,000) (4,881,000)
Cash Flows from Financing Activities    
Tax credit receivable 1,727,000  
Payment of loans payable (56,000)  
Proceeds from long term debt 1,401,000  
Net Cash provided by Financing Activities 3,072,000  
Effects of exchange rate changes on cash and cash equivalents 93,000 (38,000)
Net decrease in cash and cash equivalents and restricted cash (1,591,000) (4,919,000)
Cash and cash equivalents and restricted at the beginning of this period 11,705,000 23,279,000
Cash and cash equivalents and restricted cash at the end of this period 10,114,000 18,360,000
Reconciliation of cash, cash equivalents, and restricted cash reported in the consolidated balance sheet    
Cash and cash equivalents 10,014,000 18,261,000
Restricted cash included in other long-term assets 100,000 99,000
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows $ 10,114,000 $ 18,360,000